New study tracks psoriasis Drug's Real-World impact on diverse skin types
Knowledge-focused
Recruiting now
This study observes 80 adults in Canada with moderate-to-severe psoriasis who are starting tildrakizumab as part of their routine care. Researchers will track changes in quality of life and skin clearance over 52 weeks, focusing on people with Fitzpatrick skin types III and above…
Sponsor: Chronicle Academy • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC